Correlation Between Nouveau Life and Gentech Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nouveau Life and Gentech Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nouveau Life and Gentech Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nouveau Life Pharmaceuticals and Gentech Holdings, you can compare the effects of market volatilities on Nouveau Life and Gentech Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nouveau Life with a short position of Gentech Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nouveau Life and Gentech Holdings.

Diversification Opportunities for Nouveau Life and Gentech Holdings

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Nouveau and Gentech is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Nouveau Life Pharmaceuticals and Gentech Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gentech Holdings and Nouveau Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nouveau Life Pharmaceuticals are associated (or correlated) with Gentech Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gentech Holdings has no effect on the direction of Nouveau Life i.e., Nouveau Life and Gentech Holdings go up and down completely randomly.

Pair Corralation between Nouveau Life and Gentech Holdings

Given the investment horizon of 90 days Nouveau Life is expected to generate 1.03 times less return on investment than Gentech Holdings. But when comparing it to its historical volatility, Nouveau Life Pharmaceuticals is 1.02 times less risky than Gentech Holdings. It trades about 0.11 of its potential returns per unit of risk. Gentech Holdings is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  0.00  in Gentech Holdings on May 7, 2025 and sell it today you would earn a total of  0.00  from holding Gentech Holdings or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy96.77%
ValuesDaily Returns

Nouveau Life Pharmaceuticals  vs.  Gentech Holdings

 Performance 
       Timeline  
Nouveau Life Pharmac 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Nouveau Life Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Nouveau Life showed solid returns over the last few months and may actually be approaching a breakup point.
Gentech Holdings 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Gentech Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak technical and fundamental indicators, Gentech Holdings demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Nouveau Life and Gentech Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nouveau Life and Gentech Holdings

The main advantage of trading using opposite Nouveau Life and Gentech Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nouveau Life position performs unexpectedly, Gentech Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gentech Holdings will offset losses from the drop in Gentech Holdings' long position.
The idea behind Nouveau Life Pharmaceuticals and Gentech Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.